Intellectual disability - microarray and sequencing
Gene: COQ5 Red List (low evidence)Green List (high evidence)
Please note this additional recent paperCreated: 15 Jun 2018, 9:55 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Publications
Variants in this GENE are reported as part of current diagnostic practice
I don't know
Comment on list classification: Changed from Amber to Red. After further investigation, the 2 families reported are the same, so with only one family being reported, there is not enough evidence to support a green rating for this gene from external clinical reviewCreated: 10 Aug 2018, 12:42 p.m.
Comment on list classification: Changed from Red to Amber. Keep Amber until more cases are published to support gene-disease associationCreated: 10 Aug 2018, 11:02 a.m.
Due to Green rating by expert reviewer this gene was reviewed again- although there initially seems to be two unrelated cases reported in the literature to date, PMID:21937992 (2011) details deep sequencing process, where COQ5 is found to be a novel ID gene, in the supplementary 2 table (no pedigree) the affected female siblings are notes as having severe ID (4 healthy siblings) and indicates the parents were 1st cousins. Although not listed in the supplementary data specific to the ethnicity of each family, the cohort is described as "136 consanguineous families with autosomal-recessive intellectual disability from Iran and elsewhere". Later in 2018 PMID:29044765 3 affected female siblings (4 healthy siblings) are reported, born to non-consanguineous parents of Iraqi-Jewish descent. However the pedigree shown indicates they were first degree cousins. It seems likely this is the same family as reported in 2011, so there is not enough evidence to rate Green as recommended by external expert review.Created: 10 Aug 2018, 10:34 a.m.
Comment on phenotypes: Added phenotype from PMID: 29044765 cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency. Malicdan MCV et al,. (2018) PMID 21937992 reported the first patients with encephalomyopa-thy, cerebellar ataxia, and additional findings in a multiplex non-consanguineous family with CoQ10 deficiency due to a biallelic duplication in COQ5.Created: 10 Aug 2018, 10:19 a.m.
Comment on publications: Added publication suggested from external expert review to support upgrading of the gene- evidence to associated gene with IDCreated: 10 Aug 2018, 9:32 a.m.
Comment on publications: added publication 21937992Created: 14 Mar 2018, 11:12 a.m.
Comment on publications: Candidate intellectual disability gene suggested by Najmabadi et al., (2011) PMID:19377476 and Grozeva et al, (2015) PMID: 26350204Created: 1 Mar 2018, 2:50 p.m.
This is a candidate intellectual disability gene from Grozeva et al., (2015) PMID: 26350204, however no evidence to date has been found to support the association between variants of this gene and an observed intellectual disability phenotype.
This gene is currently a possible DD gene in Gene2Phenotype for autosomal recessive intellectual disability Najmabadi et al., (2011) PMID:19377476.Created: 1 Mar 2018, 2:49 p.m.
Red List (low evidence)
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
AUTOSOMAL RECESSIVE MENTAL RETARDATION
Publications
Red List (low evidence)
Source Victorian Clinical Genetics Services was added to COQ5.
Gene: coq5 has been classified as Red List (Low Evidence).
Gene: coq5 has been classified as Amber List (Moderate Evidence).
Phenotypes for gene: COQ5 were set to AUTOSOMAL RECESSIVE MENTAL RETARDATION; cerebellar ataxia and static encephalomyopathy due to COQ5 C-methyltransferase deficiency
Publications for gene: COQ5 were set to 19377476; 26350204; 21937992; 29044765
Publications for COQ5 were set to 19377476; 26350204; 21937992
12.03.2018: Due to major updates completed (Phase 1, 2 and 3), this panel was promoted to Version 2 in order to reflect the major updates since November 2017 which have resulted in reviews for 836 genes added by Genomics England Curators and the Clinical Team, 130 new Green genes added to the interpretation pipeline (from 751 to 881 Green genes), and the gene total has increased from 1879 to 1927.
Publications for gene COQ5 was set to ['19377476', '26350204']
The Gel status was updated for this whole panel
The Gel status was updated for this whole panel
COQ5 was added to Intellectual disabilitypanel. Sources: Expert Review Red
COQ5 was created by ellenmcdonagh
If promoting or demoting a gene, please provide comments to justify a decision to move it.
Genes included in a Genomics England gene panel for a rare disease category (green list) should fit the criteria A-E outlined below.
These guidelines were developed as a combination of the ClinGen DEFINITIVE evidence for a causal role of the gene in the disease(a), and the Developmental Disorder Genotype-Phenotype (DDG2P) CONFIRMED DD Gene evidence level(b) (please see the original references provided below for full details). These help provide a guideline for expert reviewers when assessing whether a gene should be on the green or the red list of a panel.
A. There are plausible disease-causing mutations(i) within, affecting or encompassing an interpretable functional region(ii) of this gene identified in multiple (>3) unrelated cases/families with the phenotype(iii).
OR
B. There are plausible disease-causing mutations(i) within, affecting or encompassing cis-regulatory elements convincingly affecting the expression of a single gene identified in multiple (>3) unrelated cases/families with the phenotype(iii).
OR
C. As definitions A or B but in 2 or 3 unrelated cases/families with the phenotype, with the addition of convincing bioinformatic or functional evidence of causation e.g. known inborn error of metabolism with mutation in orthologous gene which is known to have the relevant deficient enzymatic activity in other species; existence of an animal model which recapitulates the human phenotype.
AND
D. Evidence indicates that disease-causing mutations follow a Mendelian pattern of causation appropriate for reporting in a diagnostic setting(iv).
AND
E. No convincing evidence exists or has emerged that contradicts the role of the gene in the specified phenotype.
(i)Plausible disease-causing mutations: Recurrent de novo mutations convincingly affecting gene function. Rare, fully-penetrant mutations - relevant genotype never, or very rarely, seen in controls. (ii) Interpretable functional region: ORF in protein coding genes miRNA stem or loop. (iii) Phenotype: the rare disease category, as described in the eligibility statement. (iv) Intermediate penetrance genes should not be included.
It’s assumed that loss-of-function variants in this gene can cause the disease/phenotype unless an exception to this rule is known. We would like to collect information regarding exceptions. An example exception is the PCSK9 gene, where loss-of-function variants are not relevant for a hypercholesterolemia phenotype as they are associated with increased LDL-cholesterol uptake via LDLR (PMID: 25911073).
If a curated set of known-pathogenic variants is available for this gene-phenotype, please contact us at [email protected]
We classify loss-of-function variants as those with the following Sequence Ontology (SO) terms:
Term descriptions can be found on the PanelApp homepage and Ensembl.
If you are submitting this evaluation on behalf of a clinical laboratory please indicate whether you report variants in this gene as part of your current diagnostic practice by checking the box
Standardised terms were used to represent the gene-disease mode of inheritance, and were mapped to commonly used terms from the different sources. Below each of the terms is described, along with the equivalent commonly-used terms.
A variant on one allele of this gene can cause the disease, and imprinting has not been implicated.
A variant on the paternally-inherited allele of this gene can cause the disease, if the alternate allele is imprinted (function muted).
A variant on the maternally-inherited allele of this gene can cause the disease, if the alternate allele is imprinted (function muted).
A variant on one allele of this gene can cause the disease. This is the default used for autosomal dominant mode of inheritance where no knowledge of the imprinting status of the gene required to cause the disease is known. Mapped to the following commonly used terms from different sources: autosomal dominant, dominant, AD, DOMINANT.
A variant on both alleles of this gene is required to cause the disease. Mapped to the following commonly used terms from different sources: autosomal recessive, recessive, AR, RECESSIVE.
The disease can be caused by a variant on one or both alleles of this gene. Mapped to the following commonly used terms from different sources: autosomal recessive or autosomal dominant, recessive or dominant, AR/AD, AD/AR, DOMINANT/RECESSIVE, RECESSIVE/DOMINANT.
A variant on one allele of this gene can cause the disease, however a variant on both alleles of this gene can result in a more severe form of the disease/phenotype.
A variant in this gene can cause the disease in males as they have one X-chromosome allele, whereas a variant on both X-chromosome alleles is required to cause the disease in females. Mapped to the following commonly used term from different sources: X-linked recessive.
A variant in this gene can cause the disease in males as they have one X-chromosome allele. A variant on one allele of this gene may also cause the disease in females, though the disease/phenotype may be less severe and may have a later-onset than is seen in males. X-linked inactivation and mosaicism in different tissues complicate whether a female presents with the disease, and can change over their lifetime. This term is the default setting used for X-linked genes, where it is not known definitately whether females require a variant on each allele of this gene in order to be affected. Mapped to the following commonly used terms from different sources: X-linked dominant, x-linked, X-LINKED, X-linked.
The gene is in the mitochondrial genome and variants within this can cause this disease, maternally inherited. Mapped to the following commonly used term from different sources: Mitochondrial.
Mapped to the following commonly used terms from different sources: Unknown, NA, information not provided.
For example, if the mode of inheritance is digenic, please indicate this in the comments and which other gene is involved.